Sandbox brain abscess

Revision as of 20:35, 27 January 2014 by ShiSheng (talk | contribs)
Jump to navigation Jump to search

==Brain Abscess Adapted from Sanford Guide to Antimicrobial Therapy (2010); and

J Neurosci Rural Pract. 2013 August; 4(Suppl 1): S67–S81[1]==

Click on the following categories to expand treatment regimens.

Brain Abscess

  ▸  Primary Source

  ▸  Contiguous Source

  ▸  Post-Traumatic

  ▸  Post-Surgical

  ▸  Metastatic or Cryptogenic

  ▸  Haematogenous Abscess

  ▸  Immunocompromised

Primary Source
Preferred Regimen
Cefotaxime 2 gm IV q4h
OR
Ceftriaxone 2 gm IV q12h
PLUS
Metronidazole 7.5 mg/kg q6h OR 5 mg/kg IV q12h
Alternative Regimen
Penicllin G 3-4 million units IV q4h
PLUS
Metronidazole 7.5 mg/kg q6h OR 15 mg/kg IV q12h
Contiguous source
Preferred Regimen
Metronidazole 500 mg/kg q8h
PLUS
Cefotaxime 2 g IV q6h
OR
Piperacillin/Tazobactam 4.5 g IV q6h
Post-traumatic
Preferred Regimen
Cefotaxime 2 g IV q6h
PLUS
Metronidazole 500 mg/kg q8h
PLUS OR NOT
Rifampin 10 mg/kg q24h
Post-surgical
Preferred Regimen
Linezolid 600 mg IV q12h
OR
Vancomycin 15 mg/kg loading dose or 10-15 mg/kg q6h followed by 40-60 mg/kg/24 hourly continuously infusion
PLUS
Rifampin 10 mg/kg qd
PLUS
Meropenem 1.5 g q6h or 2 g q8h
OR
Piperacillin/Tazobactam 4.5 g q6h
metastatic or cryptogenic
Preferred Regimen
Cefataxime 2 g IV q6h
PLUS OR NOT
Metronidazole 500 mg q8h
OR
Ampicillin/Sulbactam 100/50 mg/kg q6h
Haematogenous Abscess
Preferred Regimen#
Trimethoprim: 3.75-7.5 mg/kg IV/ po q6-12h
PLUS
Sulfamethoxazole: 18.75-37.5 mg/kg/day IV/po q6-12h
PLUS
Ceftriaxone 2 gm IV q12h
Alternative Regimen
Trimethoprim: 3.75-7.5 mg/kg IV/ po q6-12h
PLUS
Sulfamethoxazole: 18.75-37.5 mg/kg/day IV/po q6-12h
PLUS
Amikacin 7.5 mg/kg q12h
PLUS
Imipenem-Cilastatin 500 mg IV q6h
Immunocompromised
Preferred Regimen(for minimum of 6 wks after resolution of signs)
Pyrimethamine 200 mg po qd then 75 mg/day po
PLUS
Sulfadiazine: 1 gm po q6h if <60 kg, 1.5 gm po q6h if •60 kg
PLUS
Folinic acid 10–25 mg po qd
Alternative Regimen(for 4–6 wks after resolution of signs)
Pyrimethamine 200 mg po qd then 75 mg/day po
PLUS
Folinic acid 10–25 mg po qd
PLUS
Clindamycin 600 mg po IV q6h
OR
TMP/SMX 5/25 mg/kg po qd or IV bid
OR
Atovaquone 750 mg po q6h
Suppression therapy
Sulfadiazine: 2-4 g po q6-12h
PLUS
Pyrimethamine 25-50 mg po qd
PLUS
Folinic acid 10–25 mg po qd
OR
Trimethoprim-Sulfamethoxazole 5/25 mg/kg po or IV q12h for 30 days

:If Pseudomonas aeruginosa is suspected.

:The aim is to keep the serum levels at 15-25mg/L

:After 3-6 wks of IV therapy, switch to po therapy. Immunocompetent pts: TMP-SMX, minocycline or AM-CL x 3+months. Immunocompromised pts: Treat with 2 drugs for at least one year.

#: If multiorgan involvement some add amikacin 7.5 mg/kg q12h.

  1. Carpenter D, Jackson T, Hanley MR (1987) Protein kinase Cs. Coping with a growing family. Nature 325 (7000):107-8. DOI:10.1038/325107a0 PMID: 3808066